Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Havn Life Sciences Inc (OP: HAVLF )

0.0348 +0.0112 (+47.46%)
Streaming Delayed Price Updated: 12:14 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 500
Open 0.0348
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0236
Today's Range 0.0348 - 0.0348
52wk Range 0.0057 - 0.1500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July... 
Via Benzinga
Learn About HAVN Life's New Shares Consolidation, What Changes And What Remains
A key player in the biotech-meets-psychedelics space, HAVN Life Sciences Inc. 
Via Benzinga

Performance

YTD
-42.00%
-42.00%
1 Month
+210.71%
+210.71%
3 Month
+510.53%
+510.53%
6 Month
+190.00%
+190.00%
1 Year
+8.75%
+8.75%

More News

Read More
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Via Benzinga
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
From HAVN Life Sciences Inc.
Via AccessWire
HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
HAVN Life Sciences (HAVLF) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
Via Benzinga
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
Via Benzinga
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Via Benzinga
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
Via Benzinga
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
From Stock News Now
Via AccessWire
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Via Benzinga
Former Tilray CEO Joins Psychedelics Company
Via Benzinga
Topics Cannabis
Exposures Cannabis
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
Via Investor Brand Network
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Via Benzinga
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
Via Benzinga
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
From Havn Life Sciences Inc.
Via AccessWire
Exposures Product Safety
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
From Havn Life Sciences Inc.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Via Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Via Benzinga
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
From Havn Life Sciences Inc.
Via AccessWire
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
From Havn Life Sciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
Via Benzinga
HAVN Life Natural Health Products Now Available on Amazon.ca
From Havn Life Sciences Inc.
Via AccessWire
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
From Havn Life Sciences Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.